Savara and Mast to Merge to Progress Clinical Pipeline of Inhaled Drugs Genetic Engineering & Biotech News By John Harbison|2017-02-22T09:58:19-08:00January 9, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Savara and Mast to Merge to Progress Clinical Pipeline of Inhaled Drugs Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
